Valuation: Qiagen NV

Market Cap 9.38B 8.38B 7.8B 7.09B 13.39B 908B 13.45B 93.84B 36.77B 463B 35.24B 34.47B 1,486B P/E 2026 *
23.7x
P/E 2027 * 20.5x
Enterprise Value 10.05B 8.97B 8.35B 7.59B 14.34B 972B 14.4B 100B 39.36B 496B 37.73B 36.9B 1,591B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 4.32x
Free-Float
99.37%
Yield 2026 *
0.3%
Yield 2027 * 0.4%
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2026
Director of Finance/CFO 58 01/01/2004
Chief Operating Officer - 01/04/2022
Director TitleAgeSince
Director/Board Member 77 01/06/2011
Director/Board Member 60 08/01/2021
Director/Board Member 72 23/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-4.05% - - 9.38B
-2.59%-5.70%+50.69%+86.86% 70.61B
+3.23%-10.67%+6.27%+53.70% 51.01B
+1.56%+1.17%+8.49%+31.81% 48.1B
+0.39%+0.65%+31.14%+28.97% 42.78B
+0.87%-8.17%+293.37%+642.41% 40.67B
+1.24%-1.01%+10.74%+100.64% 40.3B
-2.13%-1.64%+8.63%+46.88% 30.59B
-0.46%-1.28%+42.23%+20.34% 28.16B
+5.32%+0.06%-5.00%-12.78% 24.36B
Average +0.52%-2.66%+49.62%+110.98% 41.84B
Weighted average by Cap. +0.49%-2.94%+51.35%+115.57%

Financials

2026 *2027 *
Net sales 2.14B 1.91B 1.77B 1.61B 3.05B 207B 3.06B 21.35B 8.37B 105B 8.02B 7.84B 338B 2.24B 2B 1.86B 1.7B 3.2B 217B 3.21B 22.43B 8.79B 111B 8.42B 8.24B 355B
Net income 418M 373M 347M 316M 597M 40.47B 599M 4.18B 1.64B 20.63B 1.57B 1.54B 66.21B 483M 432M 401M 365M 689M 46.76B 692M 4.83B 1.89B 23.84B 1.81B 1.77B 76.51B
Net Debt 662M 591M 550M 500M 945M 64.09B 949M 6.62B 2.59B 32.68B 2.49B 2.43B 105B 308M 275M 256M 233M 439M 29.8B 441M 3.08B 1.21B 15.19B 1.16B 1.13B 48.75B
Logo Qiagen NV
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2025, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.1%), the United States (47.8%), Americas (4.2%) and other (13.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Qiagen NV